BJCT-BIOJECT-needle less injection product Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : BJCT-BIOJECT-needle less injection product

Public Reply Prvt Reply Mark as Last Read File

Next 10PreviousNext

To: dorothy sg who wrote ()	2/26/1997 9:13:00 PM
From: Arthur S. Conroy	of 534

I heard from a broker that they are cash rich because of deal with a major drug firm that fell thru, but had monetary penalties for the drug company. (Had to buy large number of shares at 3.50 ea) this cash went straight to BJCT's cash reserves. Also supposed to be talking with and large drug company about a distribution deal. This stock was a 1.875 last year, now at lower end of trading range, Looks great long term and if deal comes thru short term to. If this sound like hype do your due diligence mimimum downside risk good upside potental,IMHO.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Next 10PreviousNext